2022
Phosphorylated and Phosphomimicking Variants May Differ—A Case Study of 14-3-3 Protein
KOZELEKOVÁ, Aneta, Alexandra NÁPLAVOVÁ, Tomáš BROM, Norbert GAŠPARIK, Jan ŠIMEK et. al.Základní údaje
Originální název
Phosphorylated and Phosphomimicking Variants May Differ—A Case Study of 14-3-3 Protein
Autoři
KOZELEKOVÁ, Aneta (203 Česká republika, domácí), Alexandra NÁPLAVOVÁ (203 Česká republika, domácí), Tomáš BROM (203 Česká republika, domácí), Norbert GAŠPARIK (703 Slovensko, domácí), Jan ŠIMEK (203 Česká republika, domácí), Josef HOUSER (203 Česká republika, domácí) a Jozef HRITZ (703 Slovensko, garant, domácí)
Vydání
Frontiers in Chemistry, Frontiers Media SA, 2022, 2296-2646
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
10608 Biochemistry and molecular biology
Stát vydavatele
Švýcarsko
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 5.500
Kód RIV
RIV/00216224:14740/22:00119696
Organizační jednotka
Středoevropský technologický institut
UT WoS
000777334200001
Klíčová slova anglicky
14-3-3; phosphorylation; phosphomimicking mutation; oligomeric state; dissociation constant
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 27. 10. 2024 15:22, Ing. Martina Blahová
Anotace
V originále
Protein phosphorylation is a critical mechanism that biology uses to govern cellular processes. To study the impact of phosphorylation on protein properties, a fully and specifically phosphorylated sample is required although not always achievable. Commonly, this issue is overcome by installing phosphomimicking mutations at the desired site of phosphorylation. 14-3-3 proteins are regulatory protein hubs that interact with hundreds of phosphorylated proteins and modulate their structure and activity. 14-3-3 protein function relies on its dimeric nature, which is controlled by Ser58 phosphorylation. However, incomplete Ser58 phosphorylation has obstructed the detailed study of its effect so far. In the present study, we describe the full and specific phosphorylation of 14-3-3ζ protein at Ser58 and we compare its characteristics with phosphomimicking mutants that have been used in the past (S58E/D). Our results show that in case of the 14-3-3 proteins, phosphomimicking mutations are not a sufficient replacement for phosphorylation. At physiological concentrations of 14-3-3ζ protein, the dimer-monomer equilibrium of phosphorylated protein is much more shifted towards monomers than that of the phosphomimicking mutants. The oligomeric state also influences protein properties such as thermodynamic stability and hydrophobicity. Moreover, phosphorylation changes the localization of 14-3-3ζ in HeLa and U251 human cancer cells. In summary, our study highlights that phosphomimicking mutations may not faithfully represent the effects of phosphorylation on the protein structure and function and that their use should be justified by comparing to the genuinely phosphorylated counterpart.
Návaznosti
EF18_046/0015974, projekt VaV |
| ||
GF20-05789L, projekt VaV |
| ||
MUNI/C/1562/2019, interní kód MU |
| ||
90127, velká výzkumná infrastruktura |
| ||
90129, velká výzkumná infrastruktura |
|